SMTL ID : 8bpw.2 (1 other biounit)

Crystal structure of JAK2 JH1 in complex with lestaurtinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x 2V9: Lestaurtinib(Non-covalent)

2V9.1: 21 residues within 4Å: Chain A: L.40, G.41, K.42, G.43, V.48, A.65, K.67, V.96, M.114, E.115, Y.116, L.117, P.118, G.120, S.121, R.165, N.166, L.168, G.178, D.179, F.180 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.40, A:L.40, A:L.40, A:V.48, A:K.67, A:Y.116, A:L.168, A:L.168, A:D.179 Hydrogen bonds: A:E.115, A:L.117, A:R.165 Water bridges: A:R.165

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miao, Y. et al., Structural basis for JAK2 inhibition by clinical stage inhibitors. To Be Published

Release Date

2023-11-29

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence